Clinical trial · Observational
ALDOA Expression in Bladder Urothelial Carcinoma
Immunohistochemical Expression and Prognostic Significance of ALDOA in Bladder Urothelial Carcinoma.
NCT06550947CI-TRIAL-00079783unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
1. Study the immunohistochemical expression of ALDOA in bladder urothelial cancer. 2. Correlate between ALDOA expression in specimens and different cilnicopathological factors. 3. Correlate between ALDOA expression and urothelial cancer prognosis and survival.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Immunohistochemistry | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evaluate the immunohistochemical expression of ALDOA in bladder urothelial carcinoma.
- timeFrame
- Baseline
- description
- Microscopic examination of bladder urothelial carcinoma spicemens and staining them with ALDOA marker
Secondary outcomes (1)
- measure
- Evaluate relation between ALDOA expression and cilnicopathological features and patient survival.
- timeFrame
- Baseline
- description
- Correlate between ALDOA expression and the different clinicopathological factors of patients and their survival.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All cases diagnosed as bladder urothelial cancer with known follow-up data and presence of muscle proper detected in the specimens. Exclusion Criteria: 1. Subtypes of bladder cancer other than urothelial carcinoma subtype. 2. Cases of urothelial carcinoma without known follow up data. 3. Cases of urothelial carcinoma without muscle proper detected in the specimen.
References
Publications (0)
Data not yet available
No reference posted for this study.